FinCEN Extends Beneficial Ownership Information Reporting Deadline by 30 Days

Feb 28, 2025 | Legal Compliance, News

The Financial Crimes Enforcement Network (FinCEN), which is a bureau of the U.S. Department of the Treasury (DOT), has announced an extension of the Beneficial Ownership Information (BOI) reporting deadline by 30 days, following a February 18, 2025 court ruling that...

Understanding the USPTO’s Updated Trademark Filing Process and Fee Structure for 2025

Feb 24, 2025 | Legal Compliance, News

The United States Patent and Trademark Office (USPTO) has recently announced significant updates to its trademark application process and fee structure. Effective February 18, 2025, these changes impact both domestic and international trademark applicants. This blog...

Urgent Update – FDA Ends Semaglutide Shortage: What This Means for Med Spas

Feb 21, 2025 | News

The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant shift in how compounding pharmacies, medical spas, and other businesses can offer these...

The Corporate Transparency Act Is Back: What MedSpa Owners Need to Know

Feb 21, 2025 | Legal Compliance, News

The Corporate Transparency Act (CTA) has been a hot topic in recent months, with a major legal challenge temporarily putting the law on hold. However, a federal appeals court has now reinstated the CTA, meaning businesses—including med spas—must comply with its...

Syndeo Hydrafacial Defects Spark Lawsuit: What Medspa Owners Need to Know

Feb 4, 2025 | News

A class action lawsuit alleges that the popular Hydrafacial Syndeo machine suffers from serious design flaws, leaving spa owners frustrated and financially burdened. The lawsuit, filed in October 2024, claims that The Hydrafacial Company and its parent company, The...

Pfizer’s $60M Settlement: A Warning for MedSpa Owners on Physician Payments

Jan 31, 2025 | News

A recent $60 million settlement involving Pfizer is a wake-up call for healthcare businesses—including MedSpas—about the risks of improper payments to physicians. The U.S. Department of Justice (DOJ) found that Pfizer paid doctors in ways that violated federal laws,...